Filing Details

Accession Number:
0001209191-19-046799
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-20 16:19:38
Reporting Period:
2019-08-20
Accepted Time:
2019-08-20 16:19:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1123494 Harvard Bioscience Inc HBIO Laboratory Analytical Instruments (3826) 043306140
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1538555 W Thomas Loewald C/O Harvard Bioscience, Inc.
84 October Hill Rd.
Holliston MA 01746
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-08-20 20,000 $2.53 103,200 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Includes (a) a deferred stock award of 900 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019 as described in footnote 1 above; (b) a deferred stock award of 35,100 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 16, 2019, immediately prior to the commencement of such meeting, and (ii) May 23, 2020; (c) a deferred stock award of 6,900 restricted stock units which vest quarterly in equal installments on September 30, 2019 and December 31, 2019; and (d) 60,300 shares of common stock held by the Reporting Person.